IMSL Integrated Master Securities Pvt Ltd

The key indices traded with strong gains in early afternoon trade. The Nifty marched above 22,350 mark. Pharma shares gained after declining in the two trading session. Trading could be volatile due to the March F&O series expiry today.

At 12:27 IST, the barometer index, the S&P BSE Sensex was surged 765.04 points or 1.05% to 73,758.08. The Nifty 50 index jumped 237.50 points or 1.07% to 22,361.15.

The broader market underperformed the frontline indices. The S&P BSE Mid-Cap index rose 0.58% and the S&P BSE Small-Cap index added 0.69%.

The market breadth was strong. On the BSE, 2,204 shares rose and 1,454 shares fell. A total of 131 shares were unchanged.

Derivatives:

The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, shed 0.19% to 12.68. The Nifty 28 March 2024 futures were trading at 22,510.45, at a premium of 149.3 points as compared with the spot at 22,361.15.

The Nifty option chain for the 28 March 2024 expiry showed maximum Call OI of 257 lakh contracts at the 22,500 strike price. Maximum Put OI of 307.5 lakh contracts were seen at 22,300 strike price.

Buzzing Index:

The Nifty Pharma rose 1.01% to 18,957.05. The index shed 0.25% in the two trading sessions.

Biocon (up 3.39%), Divis Laboratories (up 2.15%), Ipca Laboratories (up 2.14%), Cipla (up 1.78%) and Zydus Lifesciences (up 1.78%), Dr Reddys Laboratories (up 1.75%), Sanofi India (up 1.29%), Sun Pharmaceuticals Industries (up 1.15%), Abbott India (up 1.04%) and Granules India (up 0.85%) advanced.

On the other hand, Mankind Pharma (down 2.17%), Alkem Laboratories (down 1.62%) and Natco Pharma (down 1.18%) edged lower.

Zydus Lifesciences rose 1.78% after the company said that US Food and Drug Administration (USFDA) conducted an inspection at the SEZ Onco Injectable manufacturing plant at Ahmedabad, Gujarat.

Biocon jumped 3.39% after the company announced that it has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), U.K., for its complex formulation Liraglutide.

Stocks in Spotlight:

Latent View Analytics advanced 4.18% after the company announced the Board approval for acquisition of 70% of outstanding equity capital in Decision Point for a total consideration of $39.1 million.

Powered by Capital Market - Live News

Company

Market Board

Important Links

Contact

	303-304, New Delhi House, 27, Barakhamba Road, New Delhi-110001.
	011-43074307-30 \| Fax: 011-43074315
Compliance Officers: Ms. Sonam Sethi for Integrated Master Securities Pvt Ltd.
	011-43074317
	compliance@integratedmaster.com
	ceo@integratedmaster.com

Integrated Master Securities Pvt Ltd: Member of NSE & BSE- SEBI Registration No-INZ000175931 | CDSL: Depository Services through Integrated Master Securities Pvt Ltd- SEBI Registration No: | NDSL: Depository Services through Integrated Master Securities Pvt Ltd- SEBI Registration No: IN-DP-499-2020 | Commodity trading through MCX & Ncdex.- SEBI registration No-INZ000033534

Please read the Risk Disclosure Document prescribed by the Stock Exchanges carefully before investing. There is no assurance or guarantee of the returns. Investment in securities market are subject to market risk, read all the related documents carefully before investing.

ATTENTION INVESTORS:
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020.
2. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month
4. Prevent Unauthorized Transactions in your demat account. Update your Mobile Number / Email ID with Integrated Master Securities Pvt. Ltd. To receive alerts on your Registered Mobile for all debit and other important transactions in your demat account and information of your transactions directly from NSDL\CDSL on the same day. Issued in the interest of investors.
5. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.

Designed, Developed and Powered By CMOTS Infotech ( ISO 9001:2015 Certified )

NASDAQ 15927.90
316.14 2.03%

DJIA 38239.66
153.86 0.40%

S&P 500 5099.96
51.54 1.02%

HANG SENG 17651.15
366.61 2.12%

NIKKEI 225 37934.76
306.28 0.81%

STRAITS TIMES 3280.10
-7.65 -0.23%

FTSE 100 8139.83
60.97 0.75%

KLSE COMPOSITE 1575.16
5.91 0.38%

JAKARTA COMPOSITE 7036.08
-119.22 -1.67%

NIFTY 22419.95
-150.40 -0.67%

× Ask Your Question